Rennova Health Inc (RNVA)

[newflow]

THE INSIDER PERCENTAGE - 14.6% + NOT 10%

CEO & DIRECTORS OWN 43333332

TOTAL INSIDERS OWN 71,333,331

On March 6, 2018, the Board of Directors (the “Board”) of Rennova Health, Inc. (the “Company”), based on the recommendation of the Compensation Committee of the Board, approved grants to employees and directors of an aggregate of 71,333,331 shares of common stock, including the following to the directors of the Company:



Seamus Lagan 26,666,667 shares
Dr. Kamran Ajami 3,333,333 shares
John Beach 3,333,333 shares
Gary L. Blum 3,333,333 shares
Christopher Diamantis 3,333,333 shares
Trevor Langley 3,333,333 shares


The shares were issued in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended, as a transaction by an issuer not involving a public offering.



Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.



The information disclosed in Item 3.02 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02.



Item 8.01. Other Events.



After accounting for the grants of shares to employees and directors of the Company and additional conversions of certain convertible securities of the Company, there were 488,097,654 shares of common stock issued and outstanding as of March 7, 2018. The Company is authorized to issue 500,000,000 shares of common stock.


https://www.sec.gov/Archives/edgar/data/931059/000149315218003098/form8-k.htm